SORIN GROUP is a global medical device company and a leader in the treatment of cardiovascular diseases.
The Company develops, manufactures and markets medical technologies for cardiac surgery and for the treatment of cardiac rhythm disorders.

Over 40 years of excellence in Research and Development.

We devote $70.1 million to R&D, accounting for over 9,4% of sales.

15% of our employees (over 500 people) work in R&D in centers in North America, France, Italy and Germany.

Our multidisciplinary teams bring together researchers from different backgrounds to offer a broad range of technical and scientific expertise.Our “Engineer-Physician intelligence Networks” provide a continuous source of knowledge and ideas in order to develop innovative therapeutic solutions for patients and healthcare professionals.

We have forged partnerships with cardiology specialists at world renowned universities and research centers across the globe.Our portfolio contains over 2,000 patents.

www.sorin.com

sorin logo

Sorin Implantable Defibrillator

At Sorin CRM, we encourage imagination. FIRST TO IMAGINE, FIRST TO INVENT embodies creativity through applied engineering excellence. Translating our imagination into clinically meaningful technology, we concentrate on what we do best: Cardiac Rhythm Management systems imagined, designed, built to improve and save lives.

2008 World’s FIRST implant of PARADYM™ SonR™ 8770 for continuous hemodynamic adjustment of CRT5,6
2005 World’s smallest ICD: OVATIO™ 3
2003 World’s FIRST pacing mode to maintain 99.9% intrinsic conduction1: AAIsafeR2
2002 World’s FIRST sensor to optimize AV & VV delay
1995 World’s FIRST dual chamber defibrillator implant: DEFENDER®
1994 World’s FIRST implant of a bi-ventricular pacing system

sorin paradym SonR d sorin paradym SonR
sorin paradym family of implantable defibrillator d sorin paradym family of implantable defibrillator



Defibrillation leads


More about SonR